Back to today’s briefing

Story perspectives

Brainomix Secures $18M to Expand AI Stroke Solutions

3/21/2025

39 8

Summary

Story summary

Brainomix, a pioneering UK AI company focused on imaging solutions for stroke and lung fibrosis, has secured $18 million in Series C funding. With backing from Parkwalk Advisors and Boehringer Ingelheim, this investment will fuel their U.S. expansion and elevate their cutting-edge AI technology, already benefiting 1.5 million patients across 300 hospitals.

1 of 1

Story summary

Brainomix, a pioneering UK AI company focused on imaging solutions for stroke and lung fibrosis, has secured $18 million in Series C funding. With backing from Parkwalk Advisors and Boehringer Ingelheim, this investment will fuel their U.S. expansion and elevate their cutting-edge AI technology, already benefiting 1.5 million patients across 300 hospitals.